(Q51556296)

7 April 2018

title

Effects of troglitazone on insulin sensitivity in HIV-infected patients with protease inhibitor-associated diabetes mellitus. (English)

1 reference

7 April 2018

1 reference

Walli R

1

1 reference

7 April 2018

Michl GM

2

1 reference

7 April 2018

Mühlbayer D

3

1 reference

7 April 2018

Brinkmann L

4

1 reference

7 April 2018

Goebel FD

5

1 reference

7 April 2018

publication date

1 April 2000

1 reference

7 April 2018

Research in Experimental Medicine

published in

1 reference

7 April 2018

volume

199

1 reference

7 April 2018

issue

5

1 reference

7 April 2018

page(s)

253-262

1 reference

7 April 2018

Metformin revisited: its actions and indications for use.

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS004330050123

Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS004330050123

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS004330050123

Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS004330050123

Validation of the low dose short insulin tolerance test for evaluation of insulin sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS004330050123

Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS004330050123

Effects of metformin on haemorheology, lipid parameters and insulin resistance in insulin-dependent diabetic patients (IDDM)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS004330050123

Effects of troglitazone and metformin on glucose and lipid metabolism: alterations of two distinct molecular pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS004330050123

Effect of troglitazone in insulin-treated patients with type II diabetes mellitus. Troglitazone and Exogenous Insulin Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS004330050123

PPAR-gamma: adipogenic regulator and thiazolidinedione receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS004330050123

Indinavir-associated lipodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS004330050123

Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS004330050123

21 January 2018

Identifiers

DOI

10.1007/S004330050123

1 reference

7 April 2018

PubMed ID

10815754

1 reference

7 April 2018